作者
Ping-xia Zhang, Jijun Cheng, Siying Zou, Anthony D D'Souza, Jonathan L Koff, Jun Lu, Patty J Lee, Diane S Krause, Marie E Egan, Emanuela M Bruscia
发表日期
2015/2/10
期刊
Nature communications
卷号
6
期号
1
页码范围
6221
出版商
Nature Publishing Group UK
简介
In cystic fibrosis (CF) patients, hyper-inflammation is a key factor in lung destruction and disease morbidity. We have previously demonstrated that macrophages drive the lung hyper-inflammatory response to LPS in CF mice, because of reduced levels of the scaffold protein CAV1 with subsequent uncontrolled TLR4 signalling. Here we show that reduced CAV1 and, consequently, increased TLR4 signalling, in human and murine CF macrophages and murine CF lungs, is caused by high microRNA-199a-5p levels, which are PI3K/AKT-dependent. Downregulation of microRNA-199a-5p or increased AKT signalling restores CAV1 expression and reduces hyper-inflammation in CF macrophages. Importantly, the FDA-approved drug celecoxib re-establishes the AKT/miR-199a-5p/CAV1 axis in CF macrophages, and ameliorates lung hyper-inflammation in Cftr-deficient mice. Thus, we identify the AKT/miR-199a-5p/CAV1 …
引用总数
2015201620172018201920202021202220232024315131882091242